AEZS (zentaris.com) Earnings per share growth this year

Official company branding of Aeterna Zentaris (AEZS)

Aeterna Zentaris (AEZS) is implementing advanced biotechnologies for the diagnosis of endocrine disorders. The 12-month relative EPS growth rate confirms the development trend, where the value 0.00 expresses the state of the metric. Macrilen's high authority in growth hormone deficiency therapy and management's adaptation following the merger create a foundation for the further strengthening of the issuer's market positions.

AEZS (Aeterna Zentaris Inc.) Earnings per share growth in current year history from 07/04/2022 to 08/17/2024

Financial and market metric breakdowns for Aeterna Zentaris Inc. (AEZS)

- stock value and consensus price forecast:
Basic company analysis:zentaris.com (AEZS)
Manufactured products of zentaris.com

For Aeterna Zentaris (AEZS), whose biotechnological developments are independent of GDP cycles, the year-over-year shift in earnings per share reflects the efficiency of its R&D strategy. This metric measures the annual dynamics of net income per share, capturing the growth or decline rates of profitability. A positive trend confirms the company's ability to monetize scientific achievements, ensuring the asset's fundamental stability regardless of the macroeconomic environment.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Eton Pharma|KMDA: Earnings per share increase in current year|Earnings per share growth in current year fulcrumtx.com (FULC)|Net earnings per share growth this year Abeona Therapeutics Inc. ABEO|Earnings growth in current year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Earnings per share trend in current year|PLRX - Earnings per share growth in current year|APLT - Earnings growth in current year|RNTX: Earnings growth in current year|Earnings per share growth rate in current year Gelteq Limited Inc (GELS)|Net earnings per share growth this year AYTU|Earnings per share growth rate in current year chemomab.com CMMB|Net earnings per share growth this year SRXH (SRx Health Solutions Inc)|PLRZ - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc